On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...